These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11161777)

  • 1. High-resolution integrated map encompassing the breast cancer loss of heterozygosity region on human chromosome 16q22.1.
    Frengen E; Rocca-Serra P; Shaposhnikov S; Taine L; Thorsen J; Bepoldin C; Krekling M; Lafon D; Aas KK; El Monéim AA; Johansen H; Longy M; Prydz H; Dorion-Bonnet F
    Genomics; 2000 Dec; 70(3):273-85. PubMed ID: 11161777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a high-resolution physical and transcription map of chromosome 16q24.3: a region of frequent loss of heterozygosity in sporadic breast cancer.
    Whitmore SA; Crawford J; Apostolou S; Eyre H; Baker E; Lower KM; Settasatian C; Goldup S; Seshadri R; Gibson RA; Mathew CG; Cleton-Jansen AM; Savoia A; Pronk JC; Auerbach AD; Doggett NA; Sutherland GR; Callen DF
    Genomics; 1998 May; 50(1):1-8. PubMed ID: 9628816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence-ready contig for the 1.4-cM ductal carcinoma in situ loss of heterozygosity region on chromosome 8p22-p23.
    Wang JC; Radford DM; Holt MS; Helms C; Goate A; Brandt W; Parik M; Phillips NJ; DeSchryver K; Schuh ME; Fair KL; Ritter JH; Marshall P; Donis-Keller H
    Genomics; 1999 Aug; 60(1):1-11. PubMed ID: 10458905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
    Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
    Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region.
    Chen T; Sahin A; Aldaz CM
    Cancer Res; 1996 Dec; 56(24):5605-9. PubMed ID: 8971163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
    Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer.
    Cleton-Jansen AM; Buerger H; Haar Nt; Philippo K; van de Vijver MJ; Boecker W; Smit VT; Cornelisse CJ
    Genes Chromosomes Cancer; 2004 Oct; 41(2):109-16. PubMed ID: 15287023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sequence-ready BAC clone contig of human chromosome 10p15 spanning the loss of heterozygosity region in glioma.
    Harada K; Nishizaki T; Maekawa K; Kubota H; Harada K; Suzuki M; Ohno T; Sasaki K; Soeda E
    Genomics; 2000 Aug; 67(3):268-72. PubMed ID: 10936048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 16 tumor-suppressor genes in breast cancer.
    Rakha EA; Green AR; Powe DG; Roylance R; Ellis IO
    Genes Chromosomes Cancer; 2006 Jun; 45(6):527-35. PubMed ID: 16518845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.
    Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER
    Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
    Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
    Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.
    Huiping C; Sigurgeirsdottir JR; Jonasson JG; Eiriksdottir G; Johannsdottir JT; Egilsson V; Ingvarsson S
    Br J Cancer; 1999 Dec; 81(7):1103-10. PubMed ID: 10584868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
    Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
    Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of a new target region of allelic loss to a 6-cM interval at 21q21 in primary breast cancers.
    Ohgaki K; Iida A; Kasumi F; Sakamoto G; Akimoto M; Nakamura Y; Emi M
    Genes Chromosomes Cancer; 1998 Nov; 23(3):244-7. PubMed ID: 9790505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast.
    Green AR; Krivinskas S; Young P; Rakha EA; Paish EC; Powe DG; Ellis IO
    Breast Cancer Res Treat; 2009 Jan; 113(1):59-66. PubMed ID: 18213475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
    Kochetkova M; McKenzie OL; Bais AJ; Martin JM; Secker GA; Seshadri R; Powell JA; Hinze SJ; Gardner AE; Spendlove HE; O'Callaghan NJ; Cleton-Jansen AM; Cornelisse C; Whitmore SA; Crawford J; Kremmidiotis G; Sutherland GR; Callen DF
    Cancer Res; 2002 Aug; 62(16):4599-604. PubMed ID: 12183414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-Mb BAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region.
    Baysal BE; Willett-Brozick JE; Taschner PE; Dauwerse JG; Devilee P; Devlin B
    Eur J Hum Genet; 2001 Feb; 9(2):121-9. PubMed ID: 11313745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.